Regeneron’s antibody cocktail for COVID-19, REGN-COV2, contains 2 neutralizing antibodies: casirivimab and imdevimab; results from the phase 1/2 trial reveal promising results for patients who were antibody-negative or had high viral loads.
Estie Mermelstein, MSN, FNP-BC
Estie Mermelstein, MSN, FNP-BC, earned her Master of Science in nursing from Columbia University School of Nursing. She has worked as a nurse in women’s health and as a nurse practitioner in family medicine. Estie also earned a Bachelor of Arts in journalism and was editor-in-chief of her undergraduate newspaper. She currently freelances in medical communications with a focus on clinician-facing content. She and her husband have three young children and live in New Jersey.